Gain detailed insights into the trading activity of Congress members for Ardagh Metal Packaging on our government trades page. Stay updated on how elected officials are investing in AMBP.

Ardagh Metal Packaging - Government Trades

Ardagh Metal Packaging

Ardagh Metal Packaging SA is a supplier of infinitely recyclable, sustainable, metal beverage cans and ends to brand owners. Its segment includes Europe and the Americas. It derives a majority of its revenue from the Americas.

Amazon logo

News

Markets

Media

Trading Ideas

AMBP

AMZN

QCOM

On CNBC&#39;s &#34;Halftime Report Final Trades,&#34; Joshua Brown of Ritholtz Wealth Management named Amazon, which hit another high, surpassing the $200 level on Friday.

Amazon, Qualcomm And A Consumer Cyclical Stock: CNBC&#39;s &#39;Final Trades&#39;

Long Ideas

NVAX

SOFI

TWLO

Jim Cramer can&#39;t recommend Twilio due to recent stock downgrade. He prefers Vistra Corp. and Constellation Energy Corp. for energy market.

Jim Cramer Says He&#39;s &#39;Going To Have To Wait&#39; On SoFi, But Recommends This &#39;Great Little Industrial Company&#39;

Analyst Color

Equities

Mid Cap

Penny Stocks

Price Target

Initiation

Analyst Ratings

The Future Of Ardagh Metal Packaging: Balancing Expansion Initiatives With Customer Concentration And Demand Trends

Small Cap

Intraday Update

Movers

ABBV

ALGN

ARAY

AREB

ATOM

AVGR

AZPN

BELFB

BURU

BXRX

CFRX

CMND

CMPR

CRKN

CROX

CXAI

ETAO

EVLO

FDMT

GETR

ALPS ETF Trusthen & Steers Global Realty Majors ETF

GSHD

HEES

HELE

HILS

IDEX

IMMX

IMRN

INAB

KALU

KUKE

LIAN

MBLY

MGRX

MOBQ

MORN

MTLS

MYNZ

NESR

NTGR

OMQS

OPGN

OPRA

OSTK

PRCT

SatixFy Communications Ltd. Ordinary Share

SATX

UCAR

VAPO

WOLF

Gainers


	Evelo Biosciences, Inc. (NASDAQ: EVLO) jumped 147.9% to $0.2479. Evelo Biosciences shares dropped 33% on Wednesday after the company announced top-line data from the fourth cohort of its EDP1815 Phase 2 trial, in which the primary endpoint was not met.


Why NETGEAR Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

ALVO

ATUS

CHDN

CHRW

COLB

NOVA

U.S. stocks traded higher, with the Dow Jones gaining over 200 points on Thursday. Here are some big stocks recording gains in today’s session.

Lennox International, Meta Platforms, Hasbro And Other Big Stocks Moving Higher On Thursday

On CNBC’s &#34;Halftime Report Final Trades,&#34;  Jenny Harrington  of Gilman Hill Asset Management said  Ardagh Metal Packaging S.A.

Bunge, Ardagh Metal Packaging And This Soft Drink Giant On CNBC&#39;s &#39;Final Trades&#39;

Short Ideas

RIVN

VRSN

On CNBC’s &#34;Halftime Report Final Trades,&#34;  Joseph Terranova of Virtus Investment Partners named  VeriSign, Inc. (NASDAQ: VRSN), which is higher month-to-date and also gai

Rivian Automotive, Stryker, Ardagh Metal Packaging And This Tech Stock Are CNBC&#39;s &#39;Final Trades&#39;

Dividends

Eurozone

Commodities

Management

Global

Corvex Management was founded in 2011 by Carl Icahn’s former right-hand man Keith Meister, and saw its assets double by 2013. Activist investor Meister used Icahn’s philosophy of being contrarian and aggressive and he received $1 billion in seed capital from George Soros.

2 High-Yielding Stocks That Carl Icahn&#39;s One-Time Right-Hand Man Holds — And You Can, Too

ISRG

On CNBC’s “Halftime Report Final Trades,” Jenny Harrington of Gilman Hill Asset Management said she had bought shares of Ardagh Metal Packaging SA (NYSE: AMBP) a few mo

Ardagh Metal Packaging, Intuitive Surgical And This Water Technology Company Are CNBC&#39;s Final Trades

AMRS

BALL

CCXI

SCHW

On CNBC’s &#34;Mad Money Lightning Round,&#34; Jim Cramer said The Charles Schwab Corporation (NYSE: SCHW) is &#34;terrific.&#34;

Why Jim Cramer Says This Financial Stock Is &#39;Terrific&#39;

Ardagh Metal Packaging S.A. Ordinary Shares

Ardagh Metal Packaging SA

Ardagh Metal Packaging S.A. Warrants, each exercisable for one Share at an exercise price of $11.50 per share

The White House has confirmed that President Biden has tested positive for COVID-19. Despite experiencing mild symptoms, the President will continue to fulfill his duties while self-isolating in Delaware. Biden took the opportunity, however, to take a dig at Tesla CEO Elon Musk and other billionaires for &#8220;funding&#8221; Donald Trump&#8217;s campaign
What Happened: The president said on X, &#8220;I&#8217;m Sick&#8221; and then went on to add, &#8220;of Elon Musk and his rich buddies trying to buy this election.&#8221; He also added a donate link to his post to fundraise for his own campaign.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">of Elon Musk and his rich buddies trying to buy this election. And if you agree, pitch in here.<a href="https://t.co/V93cYUUFQu">https://t.co/V93cYUUFQu</a>
&mdash; Joe Biden (@JoeBiden) <a href="https://twitter.com/JoeBiden/status/1813716534499393678?ref_src=twsrc%5Etfw">July 17, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Biden developed upper respiratory symptoms, including a runny nose and a cough, which led to a COVID-19 test. His doctor confirmed the positive result and stated that Biden&#8217;s symptoms remain mild, with normal respiratory rate and temperature. PCR confirmation testing is pending, <a href="https://thehill.com/homenews/administration/4778560-biden-tests-positive-for-covid-19/">reported</a> The Hill.
See Also: <a href="https://www.benzinga.com/news/24/07/39764047/trump-vs-biden-one-candidate-leaps-ahead-of-another-in-latest-survey?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Trump Vs Biden: One Candidate Leaps Ahead Of Another In Latest Survey</a>
Why It Matters: This week, Musk reportedly committed to <a href="https://www.benzinga.com/news/24/07/39784950/elon-musk-to-pour-45m-monthly-in-pro-trump-super-pac-joined-by-palantirs-joe-lonsdale-winklevoss-twi">allocating $45 million per month</a> to a new pro-Trump PAC, but he reacted to the Wall Street Journal&#8217;s report by sharing an image labeled &#8220;Fake Gnus&#8221; on social media, without providing an official comment.
Sen. Bernie Sanders (I-Vt.) also criticized Musk&#8217;s reported monthly donations to Trump&#8217;s campaign, emphasizing the <a href="https://www.benzinga.com/news/24/07/39807458/bernie-sanders-slams-elon-musks-reported-45m-donations-to-trump-campaign-we-need-a-government-that-r">need for public election funding</a>. Sanders stressed overturning Citizens United to prevent billionaires from dominating politics. 
Image via Shutterstock
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/politics/24/07/39805974/trumps-big-mistake-fivethirtyeight-now-shows-biden-as-favorite-to-win-election-following-j-d-van?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Trump&#8217;s Big Mistake? FiveThirtyEight Now Shows Biden As Favorite To Win Election Following J.D. Vance VP Pick, Despite Polling Data</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

Biden Gets COVID-19, Takes A Fiesty Dig At Tesla CEO: 'I'm Sick …Of Elon Musk And His Rich Buddies Trying To Buy This Election'

LUCYW

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

SONM

TCRT

LUCY

SNTI

MGOL

The Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) have intensified their oversight of the <a href="http://benzinga.com/cannabis" target="_blank" rel="noreferrer noopener">cannabis</a> industry, issuing another round of warning letters to companies on Tuesday. The businesses are accused of selling products infused with <a href="https://www.benzinga.com/markets/cannabis/24/01/36584043/real-weed-or-a-lab-high-delta-8-and-delta-9-thc-explained" target="_blank" rel="noreferrer noopener">hemp-derived cannabinoids</a>, such as delta-8 THC, in packaging deceptively resembling popular children's snacks.
This move marks the second consecutive year of such actions, signaling a tightening grip on deceptive marketing practices.
<h3 class="wp-block-heading">FTC Targets Deceptive THC Edibles Marketing</h3>
&#8220;Companies that market and sell edible THC products that are easily mistaken for snacks and candy are not only acting illegally, but they are also putting the health of young children at risk,&#8221; Samuel Levine, director of FTC's Bureau of Consumer Protection <a href="https://www.fda.gov/news-events/press-announcements/fda-ftc-continue-joint-effort-protect-consumers-against-companies-illegally-selling-copycat-delta-8" target="_blank" rel="noreferrer noopener">stated</a> in a press release. As Hemp Today <a href="https://hemptoday.net/federal-ban-on-delta-8-other-hemp-derived-intoxicants-could-come-as-early-as-october/" target="_blank" rel="noreferrer noopener">notes</a>, this regulatory spotlight aligns with concerns over delta-8 THC, delta-10 THC, THC-O-acetate, HHC, THCP, and hemp-derived THCA &#8211; substances gaining notoriety for their psychoactive effects yet slipping through legislative cracks.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Today, the FDA and <a href="https://twitter.com/FTC?ref_src=twsrc%5Etfw">@FTC</a> issued warning letters to five companies for illegally selling copycat food products containing Delta-8 THC and introducing them into the marketplace in violation of the Federal Food, Drug, and Cosmetic Act. These warnings serve as part of the FDA and… <a href="https://t.co/71cmdHNk3S">pic.twitter.com/71cmdHNk3S</a>
&mdash; U.S. FDA (@US_FDA) <a href="https://twitter.com/US_FDA/status/1813259864497434910?ref_src=twsrc%5Etfw">July 16, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Real Also: <a href="https://www.benzinga.com/markets/cannabis/24/07/39783607/how-hemp-became-americas-loophole-for-legal-highs" target="_blank" rel="noreferrer noopener">How Hemp Became America&#8217;s Loophole For Legal Highs</a>
<h3 class="wp-block-heading">Congress Debates Hemp Cannabinoid Ban</h3>
Simultaneously, a heated debate is unfolding in Congress about the future legality of consumable hemp-based cannabinoid products. Proposals in recent <a href="https://www.benzinga.com/markets/cannabis/24/07/39698531/gop-led-congressional-committee-passes-bill-to-block-cannabis-rescheduling-deny-state-protection" target="_blank" rel="noreferrer noopener">House-approved appropriations legislation</a> and the forthcoming Farm Bill <a href="https://www.benzinga.com/markets/cannabis/24/05/39006814/house-committee-approval-of-amendment-eliminating-90-of-hemp-dervied-products-could-drive-wedge-" target="_blank" rel="noreferrer noopener">hint at a potential nationwide ban</a>. These legislative actions are compounded by concerns over unregulated cannabis products that make unauthorized health claims.
<h3 class="wp-block-heading">Unknown Compounds From Hemp Conversion Found In Tests</h3>
Amidst this regulatory and legislative flux, a new concern arises from the discovery of numerous unknown compounds in marijuana testing samples, <a href="https://mjbizdaily.com/unknown-compounds-found-in-cannabis-testing-samples-lab-owners-say/" target="_blank" rel="noreferrer noopener">reported</a> by MJBizDaily. These compounds are believed to originate from the process of converting hemp-derived cannabinoids into delta-8 and delta-9 THC. &#8220;These are chemical side reactions,&#8221; explained Susan Audino, a chemist and independent consultant to chemical laboratories.
Josh Swider, CEO of Infinite Chemical Analysis Labs said, &#8220;You'll see 60 unknown compounds in there. Some of them get identified, but all of them are never found. That is telling you that you're now adding other compounds that we never found in cannabis, and now people are smoking it. It's a very common thing going on around the country.
<h3 class="wp-block-heading">FDA Faces CBD Regulation Criticism</h3>
<a href="https://www.benzinga.com/markets/cannabis/23/04/31890021/house-committee-to-investigate-fda-inaction-on-cbd-regulation-gop-chair-warns-about-dangers" target="_blank" rel="noreferrer noopener">The FDA's ongoing failure to regulate CBD</a>, criticized by stakeholders and legislators alike, adds another layer of urgency to these discussions. In a House committee hearing earlier this year, FDA commissioner Robert Califf <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38226873/analyst-reacts-to-fda-commish-comments-medical-and-recreational-cannabis-could-have" target="_blank" rel="noreferrer noopener">addressed criticisms over the agency&#8217;s inaction</a>, suggesting that resolving these issues would require additional congressional support. This legislative backdrop sets the stage for potential sweeping reforms in how hemp-derived products are marketed and regulated.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/07/39610764/intoxicating-hemp-products-face-regulatory-crackdown-across-multiple-states" target="_blank" rel="noreferrer noopener">Intoxicating Hemp Products Face Regulatory Crackdown Across Multiple States</a></li>
</ul>
<hr class="wp-block-separator has-alpha-channel-opacity" />
Cannabis rescheduling seems to be right around the corner. Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. <a href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" target="_blank" rel="noreferrer noopener">Get your tickets now</a> before prices surge by following <a href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" target="_blank" rel="noreferrer noopener">this link</a>.

Cannabis

Government

Regulations

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

FDA Accuses Companies Of Marketing Cannabis Products To Children Amid Debate On Hemp Cannabinoids Ban

Kentucky Governor Andy Beshear is urging the Drug Enforcement Administration (DEA) to ease <a href="https://www.benzinga.com/markets/cannabis/24/07/39715542/biden-administration-give-us-more-insight-on-marijuana-rescheduling-decision-congressional-commi">restrictions on marijuana. </a>
In a recent letter addressed to DEA administrator Anne Milgram, Beshear advocated for the reclassification of cannabis from a Schedule I drug, which includes substances like heroin and LSD, to a Schedule III drug, where ketamine and anabolic steroids are listed, Cannabis Business Times <a href="https://www.cannabisbusinesstimes.com/news/dea-reschedule-marijuana-schedule-iii-when-kentucky-governor-andy-beshear-controlled-substances/">reported.</a>
See Also: <a href="https://www.benzinga.com/markets/cannabis/24/06/39277690/dea-vs-biden-fda-health-agency-over-cannabis-rescheduling-whats-up-with-that">DEA Vs. Biden, FDA &amp; Health Agency Over Cannabis Rescheduling: What&#8217;s Up With That?</a>
&#8220;The jury is no longer out on marijuana: It has medical uses and is currently being used for medical purposes,&#8221; Beshear wrote. &#8220;The recognition is overwhelming – and bipartisan. For example, I signed a medical marijuana law that passed with support from Republican legislative supermajorities and a Democratic Governor.&#8221;
<h3 class="wp-block-heading">Medical Marijuana In Kentucky</h3>
Kentucky&#8217;s approach to medical marijuana has evolved significantly under Beshear&#8217;s administration. The governor signed a medical marijuana law that passed with bipartisan support, highlighting the broad acceptance of cannabis&#8217;s medicinal benefits.
Beshear&#8217;s letter comes at a crucial time, with the new medical cannabis program set to go into effect on January 1, 2025. This program aims to provide safe, regulated medical marijuana products to improve the lives of Kentuckians with significant medical conditions.
<h3 class="wp-block-heading">The Case For Rescheduling Cannabis</h3>
The primary distinction between Schedule I and Schedule III drugs lies in their medical value and potential for abuse. Schedule I drugs are deemed to have no medical value and a high potential for abuse, whereas Schedule III drugs have accepted medical uses and a lower potential for abuse. 
According to DEA scheduling practices, marijuana is absurdly classified as more dangerous than fentanyl, oxycodone and methamphetamine. 
Beshear&#8217;s argument is bolstered by data from the Centers for Disease Control and Prevention (CDC), which estimated that 84,181 people died from opioid overdoses in 2022. In contrast, the DEA has not reported any deaths directly attributable to marijuana use.
However, a 2023 study from Florida Atlantic University highlighted that synthetic cannabinoids, which are often more potent and dangerous than natural cannabis, have been linked to 386 deaths between 2014 and 2020.
<h3 class="wp-block-heading">Potential Benefits For Kentuckians</h3>
Beshear emphasized the potential benefits of rescheduling marijuana for Kentuckians, particularly as an alternative to opioids and a means to reduce crime and illicit drug use. &#8220;
As Governor, my job is to move our state forward,&#8221; Beshear stated. &#8220;Rescheduling marijuana to Schedule III is a significant, common-sense step forward for all Kentuckians, especially those with significant medical conditions.&#8221;
<h3 class="wp-block-heading">Looking Ahead</h3>
Kentucky&#8217;s new medical cannabis program is set to launch in 2025, promising to bring relief to thousands of residents suffering from various medical conditions. 
&#8220;We look forward to seeing how safe medical marijuana products will reduce the suffering and improve the lives of tens of thousands of Kentuckians when our program launches,&#8221; Beshear wrote.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/05/39011156/exclusive-we-analyzed-4-000-dea-marijuana-rescheduling-comments-heres-what-americans-really-thin">EXCLUSIVE: We Analyzed 4,000+ DEA Marijuana Rescheduling Comments; Here&#8217;s What Americans Really Think</a></li>
</ul>
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/07/39617358/dea-veteran-warns-bidens-plan-to-reclassify-marijuana-will-empower-mexican-chinese-cartels"><a href="https://www.benzinga.com/markets/cannabis/24/06/39537843/applications-open-kentucky-set-to-roll-out-medical-cannabis-in-2025">Applications Are Open: Kentucky Set To Roll Out Medical Cannabis In 2025</a></a></li>
</ul>
Government photo of Andy Beshear

Politics

Kentucky Gov Andy Beshear To DEA: Reschedule Cannabis 'Marijuana Products Will Reduce Suffering'

The facilities, reportedly functioning as fronts for the distribution of cannabis other substances were shut down early Wednesday in what officials describe as one of the largest busts seen by New York Police Dept. (NYPD) and Sheriff&#8217;s Office recently.
The raid comes as part of city-wide clean-up operation, known as <a href="https://www.benzinga.com/markets/cannabis/24/05/38875243/nyc-mayor-adams-on-the-weed-warpath-6m-in-fines-75-closures-4000-illicit-shop-violations-in-firs">Operation Padlock</a>, which has been underway since May of this year.
It is believed that the total illicit cannabis selling shops functioning in <a href="https://www.benzinga.com/topic/new-york-cannabis">NYC</a> amounts to 3600. On ABC7&#8217;s Eyewitness, NYPD chief of patrol John Chell <a href="https://abc7ny.com/post/2-bronx-businesses-raided-nypd-new-york-city/15064172/">said</a> &#8220;we&#8217;ve shut down 18 percent of those stores in six weeks.&#8221;
Authorities raided a location on East Tremont Avenue where the NYPD uncovered 176 pounds of cannabis flower, 0.6 pounds of THC vape products and psilocybin mushroom edibles. The cannabis flower was hidden in various places including in compartments under a couch, covered by ceiling tiles, in filing cabinets, in luggage bags and some in plain view.
Chell said that the bust came after the police responded to a community complaint about a deli that ended up being a cover for an illegal drug distribution center.
Read Also:<a href="https://www.benzinga.com/markets/cannabis/24/05/38875243/nyc-mayor-adams-on-the-weed-warpath-6m-in-fines-75-closures-4000-illicit-shop-violations-in-firs"> NYC Mayor Adams On The Weed Warpath: $6M In Fines, 75 Closures, 4000 Illicit Shop Violations In First Week Of &#8216;Operation Padlock To Protect&#8217;</a>
&#8220;Behind the back door it was like the Cesar&#8217;s palace of illegal marijuana, vapes, psychedelic mushrooms&#8230;&#8221;
&#8220;These are all mushroom bars, cereal milk, white chocolate, birthday cake, different flavors,&#8221; explained Lt. Francesca Rosa from the NYC Sheriff&#8217;s Office. &#8220;All of these products are unregulated, unlicensed, this location is unlicensed, they should not have any of this product here.&#8221;
Just blocks away, another establishment on East Tremont Avenue was allegedly functioning as a front for illicit cannabis storage and distribution.
Two workers were arrested during the raid. 
While NYC authorities are moving aggressively to close down unlicensed cannabis shops, the legal cannabis market has been limping along at a disappointedly <a href="https://www.benzinga.com/markets/cannabis/24/07/39777553/is-the-worst-over-for-new-yorks-beleaguered-weed-market-sales-projections-optimistic-though-cann">slow</a> rhythm. As a result, the gap between issued licenses and operational dispensaries continues to <a href="https://www.benzinga.com/markets/cannabis/24/07/39694320/licensed-but-closed-new-yorks-cannabis-dream-faces-bureaucratic-nightmare">widen</a>.
Out of 1,117 licenses issued by the Office of Cannabis Management (OCM), only about 141 dispensaries are operational. This is due mainly to bureaucratic and legal struggles. Additionally, the state&#8217;s <a href="https://www.benzinga.com/markets/cannabis/24/04/38230512/its-a-green-day-in-new-york-137-cannabis-licenses-granted-new-jersey-still-in-the-lead">social equity</a> licenses, meant to support those affected by past drug laws and impacted communities, lack sufficient funding and logistical support.
<ul>
<li>Read Next:<a href="https://www.benzinga.com/markets/cannabis/24/06/39322748/unlicensed-cannabis-sellers-fight-back-suing-nyc-for-unconstitutional-crackdowns"> Unlicensed Cannabis Sellers Fight Back, Suing NYC For &#8216;Unconstitutional&#8217; Crackdowns</a></li>
</ul>

NYC Cops Raid Two Bronx Cannabis Operations, One Was Like 'The Cesar's Palace Of Illegal Marijuana'

The Company is a closed-end, registered fund that will trade on the New York Stock Exchange under the ticker &quot;PDCC.&quot; The offering is expected to close on&nbsp;July 19, 2024, subject to customary closing conditions.
The Company intends to use the proceeds from the capital raised to build a diversified portfolio of senior secured U.S. corporate loans through investments in equity tranches of collateralized loan obligations (CLOs).

IPOs

Pearl Diver Credit Company Reports Pricing Of Its Upsized IPO Of 2.2M Shares At $20 Per Share

Former President Donald Trump previously tried to ban TikTok, but had a reversal of opinion on the Chinese-owned app as a potential <a href="https://www.benzinga.com/markets/equities/24/06/39470496/joe-bidens-tiktok-ban-could-adversely-impact-oracles-revenue-and-profit-tech-giant-warns">U.S. ban is nearing.</a>
What Happened: In a recent interview, Trump said that big technology companies like Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>)- owned Facebook and Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>)-owned Google and YouTube have become too big and too powerful, something that <a href="https://www.benzinga.com/topic/tiktok">supports having TikTok</a> around for competition.
"I think they're having a huge negative impact on especially young people," Trump said of big technology companies in an interview with <a href="https://www.bloomberg.com/features/2024-trump-interview-transcript/?embedded-checkout=true&amp;sref=TBDibEcD">Bloomberg</a>.
Trump said TikTok is "very powerful."
Asked about a reversal on wanting to ban TikTok, Trump shares his opinion on the need for competition to big technology companies.
"I'm for TikTok because you need competition. If you don't have TikTok, you have Facebook and Instagram, and that's, you know, that's Zuckerberg."
Trump recalled Meta Platforms CEO Mark Zuckerberg banning him from Facebook and Instagram in the interview.
"I went from being No. 1 to having nobody."
Trump had a two-year ban from Facebook and Instagram after the Jan. 6, 2021, attack on the U.S. Capitol over concerns of civil unrest. Trump <a href="https://www.benzinga.com/news/23/02/30848473/trumps-back-on-facebook-and-instagram-for-real">was welcomed back</a> to the platforms in 2023 and recently saw all restrictions lifted.
The former president has also been welcomed back on social media platform X, formerly known as Twitter. While Trump prefers to post on his own social media platform Truth Social, which is owned by Trump Media &amp; Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>), he often uses Facebook to communicate with his followers.
Read Also: <a href="https://www.benzinga.com/news/24/07/39759624/meta-removes-heightened-penalties-on-donald-trumps-accounts-a-day-after-ex-president-threatens-to-pu">Meta Removes &#8216;Heightened Penalties&#8217; On Donald Trump&#8217;s Accounts A Day After Ex-President Threatens To Put Mark Zuckerberg In Jail</a>
Why It's Important: Trump <a href="https://www.benzinga.com/news/24/03/37572294/donald-trump-is-against-tiktok-ban-because-it-would-help-facebook-and-zuckerschmuck-double-their-bus">previously said he</a> is against a ban on TikTok in the U.S. as it could prove advantageous to Facebook and Zuckerberg.
"If you get rid of TikTok, Facebook and Zuckerschmuck will double their business," Trump previously said.
Trump said he doesn't want Facebook to do better as he alleged the company cheated in the 2020 election.
"They are a true Enemy of the People!"
Trump has shown strong opposition to Zuckerberg in recent months. The former president specifically named Zuckerberg as an "election fraudster" who he could<a href="https://www.benzinga.com/news/24/07/39723781/trump-threatens-to-jail-metas-mark-zuckerberg-and-election-fraudsters-if-re-elected-dont-do-it-be-ca"> put in prison</a> if he is elected to the White House.
"They have no shame! All I can say is that if I'm elected President, we will pursue Election Fraudsters at levels never seen before, and they will be sent to prison for long periods of time."
Trump's negativity towards Zuckerberg dates <a href="https://www.benzinga.com/general/social-media/24/04/38152630/if-you-invested-1-000-in-meta-platforms-stock-when-donald-trump-said-facebook-was-always-ant">back several years</a> with the former president accusing Facebook of always being "anti-Trump."
In April, Congress and President Joe Biden signed legislation to force a sale of the U.S. arm of ByteDance-owned TikTok or see the app banned in America.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/04/38368049/trump-reverses-tiktok-ban-stance-accuses-biden-of-favoring-zuckerbergs-meta-doing-it-to-help-faceboo">Trump Reverses TikTok Ban Stance, Accuses Biden Of Favoring Zuckerberg&#8217;s Meta: &#8216;Doing It To Help Facebook Friends Get Richer&#8217;</a></li>
</ul>
Photos: Shutterstock

Social Media

GOOG

GOOGL

Trump 'For TikTok,' Competition To Mark Zuckerberg: 'If You Don't Have TikTok, You Have Facebook And Instagram'

This expansion will add 1.3 million premium seats annually to mainline fleet,&nbsp;providing guests with even more opportunities to upgrade to a premium experience.

Alaska Airlines To Begin Rolling Out Additional First Class And Premium Class Seating Across More Than 200 Of Its Aircraft

Governor Ron DeSantis went there at the<a href="https://www.benzinga.com/topic/rnc"> Republican National Convention</a> (RNC) in Milwaukee on Wednesday: He used his platform to rail against Florida's upcoming vote to <a href="https://www.benzinga.com/markets/cannabis/24/04/38034138/florida-supreme-court-approves-cannabis-legalization-proposal-for-november-election-in-blow-to-d" target="_blank" rel="noreferrer noopener">legalize recreational marijuana</a> telling his comrades that if weed is legalized, people will be able to possess practically limitless amounts of the stuff.    
"It gives you a limitless constitutional right to possess and smoke. I think it's up to like, what, 40 joints, is that the three ounces would be 40? More than that, 80 joints. Something like that," he said. 
In fact, he noted that if the cannabis legalization ballot wins, marijuana rights will surpass the constitutional guarantees of the First and Second Amendments concerning free speech and gun ownership, respectively. And that&#8217;s a statement he&#8217;s already made in the past.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/06/39492507/desantis-says-cannabis-legalization-amendment-will-protect-weed-rights-better-than-1st-2nd-amend">DeSantis Says Cannabis Legalization Amendment Will Protect Weed Rights Better Than 1st, 2nd Amendments Protect Free Speech, Gun Rights</a>
<h2 class="wp-block-heading">Counting Joints</h2>
The language in the legalization initiative, known as Amendment 3, would allow people to possess three ounces of flower or five grams of concentrate, which translates to roughly 27 joints per ounce according to the Governor's math.
"I think you're going to see people, you will be able to bring 20 joints to an elementary school. Is that really going to be good for the state of Florida? I don't think so," DeSantis <a href="https://www.benzinga.com/markets/cannabis/24/06/39311053/desantis-blasts-cannabis-legalization-amendment-says-people-will-be-able-to-bring-20-joints-to-a">said</a> in June.
The governor has issued similar warnings about the dangers of cannabis legalization, but the number of joints he references seems to increase with each tirade, noted Florida Politics, which first <a href="https://floridapolitics.com/archives/684696-ron-desantis-now-says-weed-legalization-would-let-people-have-80-joints-at-a-time/">reported</a> this story from the RNC.
<h2 class="wp-block-heading">Smoky Restaurants</h2>
DeSantis went on to paint a scenario of unchecked public weed consumption, including in private businesses such as restaurants, which he claimed would be difficult to regulate due to the amendment&#8217;s broad language.
"I think you're talking about going downtown somewhere, going to restaurants, all this —you are going to see this. And law enforcement's not going to want to police it at all," he said. "I've had some restaurant guys [say], ‘Well, I won't let them use it in my restaurant,&#8217;" DeSantis continued. "Well, I'm not sure you're going to be able to do that, given how broad it is."
DeSantis also repeated a <a href="https://www.benzinga.com/markets/cannabis/24/06/39346531/desantis-cant-get-past-the-odor-of-weed-to-smell-the-flowers-specifically-430m-annually-in-canna">complaint</a> that seems to have become the bane of his existence: the smell.
"You go to places like Denver. It smells like marijuana," he told the crowd. "It's not been good for quality of life. So that's just the reality. We've seen in in practice in a lot of places. It hasn't delivered what they said it would deliver."
During his speech, DeSantis also linked marijuana legalization with another initiative, Amendment 2, on expanding abortion access. He called on Florida Republicans assembled in Milwaukee to oppose both measures in order to maintain conservative values. 
Now Read:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/07/39760907/ron-desantis-floridas-gop-and-hemp-industry-pile-on-to-defeat-marijuana-legalization">Ron DeSantis, Florida&#8217;s GOP And Hemp Industry Pile On To Defeat Marijuana Legalization</a></li>
</ul>
Photo: Benzinga edit with images by&nbsp;<a href="https://en.wikipedia.org/wiki/Ron_DeSantis#/media/File:Ron_DeSantis-crop.jpg" target="_blank" rel="noreferrer noopener">Wikimedia Commons&nbsp;</a>and&nbsp;<a href="https://www.pexels.com/photo/close-up-photo-of-cannabis-plant-7667883/" target="_blank" rel="noreferrer noopener">Kindel Media</a>&nbsp;on Pexels

Events

LASE

Ron DeSantis Blasts Florida's Cannabis Legalization Ballot At RNC: It Would Allow '80 Joints' A Day, Affecting Free Speech And Gun Rights

Earnings

TIRX

TIAN RUIXIANG Holdings Reports FY23 EPS Of $(3.87) Vs $(9.03) Last Year; Revenue Decrease By 8.0% To $1.2M

Wells Fargo analyst Mike Mayo maintains State Street (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STT#NYSE">STT</a>) with a Overweight and raises the price target from $91 to $98.

Wells Fargo Maintains Overweight on State Street, Raises Price Target to $98

Capital One Financial Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COF#NYSE">COF</a>) shares are trading higher Wednesday. Capital One aims to acquire Discover Financial Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DFS#NYSE">DFS</a>), which reported better-than-expected <a href="https://www.benzinga.com/news/earnings/24/07/39826835/discover-reports-better-than-expected-q2-results-heres-the-details">second-quarter results after the bell.</a> 
The Details: Discover shares are trading higher after the company reported GAAP earnings of $6.06 per share, beating the estimate of $3.07 per share, and quarterly Net Interest Income (NII) of $3.524 billion.
Additionally, Capital One announced a <a href="https://www.benzinga.com/pressreleases/24/07/b39815404/capital-one-announces-five-year-265-billion-community-benefits-plan-in-connection-with-discover-ac">community benefits plan</a> Wednesday that commits more than $265 billion in lending, investment and philanthropy over five years as part of its <a href="https://www.benzinga.com/m-a/24/02/37204534/capital-one-set-to-acquire-discover-in-landmark-35-3b-deal">proposed acquisition</a> of Discover. 
Capital One said the plan is twice as large as any other community commitment developed in connection with a bank acquisition and demonstrates that the combination of Capital One and Discover will create an opportunity to provide more lending, investment, and services to underserved communities than the institutions would undertake on a stand-alone basis.
Read Next:<a href="https://www.benzinga.com/news/24/07/39796841/lucids-stock-drives-higher-on-2025-model-year-updates-whats-going-on"> Lucid&#8217;s Stock Drives Higher On 2025 Model Year Updates: What&#8217;s Going On?</a>
&#8220;Our commitments to financial inclusion and well-being are core to who we are as a company,&#8221; said Richard Fairbank, CEO of Capital One.&nbsp;
&#8220;That comes to life in our product portfolio, which serves the full spectrum of American consumers, and in the investments we make in our communities. We have a long history of developing innovative ways to serve these core constituencies, and we are committed to ensuring, through this community benefits plan, that our acquisition of Discover builds on our history of positive impact.&#8221;&nbsp;
COF Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Capital One shares are up 3.16% after-hours at $154.20 at the time of publication Wednesday.
Read Also:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/07/39805320/what-happened-with-canopy-growth-stock-today">What Happened With Canopy Growth Stock Today?</a></li>
</ul>
Image: Shutterstock

After-Hours Center

Why Capital One Stock Is Climbing

Opko Health Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPK#NASDAQ">OPK</a>) shares are trading higher after-hours Wednesday. The company announced it entered into a $250 million non-dilutive note purchase <a href="https://www.benzinga.com/pressreleases/24/07/g39825467/opko-health-and-healthcare-royalty-enter-into-250-million-note-purchase-agreement-secured-by-ngenl">agreement with HealthCare Royalty (HCRx). </a>
The Details: Opko said the purchase agreement is secured by its profit share payments from Pfizer received pursuant to its license agreement relating to NGENLA, a once-weekly treatment to treat pediatric growth hormone deficiency. 
The $250 million note issued under the Note Purchase Agreement bears interest at the 3-month Secured Overnight Financing Rate (SOFR) subject to a 4% per annum floor, plus 7.5% per annum. The note has a final maturity date of July 2044 with the first four years requiring interest-only payments.
Read Next:<a href="https://www.benzinga.com/news/24/07/39796841/lucids-stock-drives-higher-on-2025-model-year-updates-whats-going-on"> Lucid&#8217;s Stock Drives Higher On 2025 Model Year Updates: What&#8217;s Going On?</a>
&#8220;This transaction with HCRx allows OPKO to retain a significant portion of NGENLA&#8217;s profit share payments in the near term and provides upside over the long term. It also permits OPKO to maintain the full benefit of the $100 million of remaining potential milestone payments from Pfizer,&#8221; said Phillip Frost, M.D., CEO of Opko.
&#8220;Additionally, it provides non-dilutive capital and financial flexibility to advance our research and development activities including our multispecific antibody programs, as well as potentially to repurchase shares of our common stock and convertible notes."
OPK Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Opko Health shares are up 7.07% after-hours at $1.52 at the time of publication Wednesday.
Read Also:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/07/39805320/what-happened-with-canopy-growth-stock-today">What Happened With Canopy Growth Stock Today?</a></li>
</ul>
Image: Shutterstock

Health Care

Why Opko Health Shares Are Up After-Hours

Parker Hannifin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PH#NYSE">PH</a>) has outperformed the market over the past 20 years by 5.96% on an annualized basis producing an average annual return of 14.47%. Currently, Parker Hannifin has a market capitalization of $71.72 billion. 
Buying $100 In PH: If an investor had bought $100 of PH stock 20 years ago, it would be worth $1,497.16 today based on a price of $557.94 for PH at the time of writing.
<h3>Parker Hannifin's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721251823_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In This Stock 20 Years Ago Would Be Worth $1,500 Today

Cintas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTAS#NASDAQ">CTAS</a>) has outperformed the market over the past 15 years by 13.08% on an annualized basis producing an average annual return of 25.38%. Currently, Cintas has a market capitalization of $73.03 billion. 
Buying $100 In CTAS: If an investor had bought $100 of CTAS stock 15 years ago, it would be worth $3,060.29 today based on a price of $719.78 for CTAS at the time of writing.
<h3>Cintas's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721251818_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CTAS

Here's How Much $100 Invested In Cintas 15 Years Ago Would Be Worth Today

Companies in the Consumer Cyclical sector have received a lot of coverage today as analysts weigh in on Mohawk (MHK – Research Report), O'Reilly Au...

Analysts Offer Insights on Consumer Cyclical Companies: Mohawk (MHK), O'Reilly Auto (ORLY) and Ardagh Metal Packaging (AMBP)

Companies in the Consumer Cyclical sector have received a lot of coverage today as analysts weigh in on Mohawk (MHK – Research Report), Ardagh Meta...

Analysts Offer Insights on Consumer Cyclical Companies: Mohawk (MHK), Ardagh Metal Packaging (AMBP) and Jack In The Box (JACK)

In a report released today, Michael Roxland from Truist Financial reiterated a Hold rating on Ardagh Metal Packaging (AMBP – Research Report), with...

Truist Financial Reaffirms Their Hold Rating on Ardagh Metal Packaging (AMBP)

Ardagh Metal Packaging: Stubbornly Maintaining Its 10% Dividend Yield

Silgan Holdings: Earnings Are Proof That There Are Better Prospects Out There

Analysts fell to the sidelines weighing in on Ardagh Metal Packaging (AMBP – Research Report), Beyond Inc (BYON – Research Report) and Olaplex Hold...

Analysts Offer Insights on Consumer Cyclical Companies: Ardagh Metal Packaging (AMBP), Beyond Inc (BYON) and Olaplex Holdings (OLPX)

Analysts have been eager to weigh in on the Consumer Cyclical sector with new ratings on Cracker Barrel (CBRL – Research Report), Ardagh Metal Pack...

Analysts Offer Insights on Consumer Cyclical Companies: Cracker Barrel (CBRL), Ardagh Metal Packaging (AMBP) and Inspired Entertainment (INSE)

Stocks with the highest and lowest liquidity - Goldman Sachs

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Navigating the world of high yield <a href="https://investorplace.com/stock-types/dividend-stocks/">dividend stocks</a> can be difficult. While those high yields reduce overall investor risk when share prices go down, they also require significant capital for their continued payment. Generally speaking, the higher a dividend yield, the greater the overall risk. Dividend yields in the 2% to 6% range are considered ideal. Dividends yielding more than 6% are generally considered at risk.



And while dividend yields are one way of measuring risk, there are plenty of others. Payout ratio is one which is particularly useful. It measures the amount of profits a company pays out as dividends. Ratios between 35% to 55% are considered healthy.&nbsp;



Each of the at-risk dividend stocks discussed below deviates from one or both of those healthy ranges. So, as appealing as they may be to income investors seeking dividend cash, they&rsquo;re probably too risky because either their share price, dividend or both are at risk of falling further.&nbsp;



<h2>Walgreens Boots Alliance (W<a href="https://investorplace.com/stock-quotes/-stock-quote/"></a>BA)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/08/wba1600-300x169.jpg" alt="Walgreens (WBA) store exterior and sign in Pompano Beach, Florida"><div>Source: saaton / Shutterstock.com</div></div>Walgreens Boots Alliance (NYSE:<a href="https://investorplace.com/stock-quotes/wba-stock-quote/">WBA</a>) is a well-known pharmaceutical retailer with a stock that is headed in the wrong direction. In fact, WBA shares have fallen from $26 to below $16 in 2024.



I think Walgreens Boots Alliance is primarily at risk of further share price deterioration due to recent dividend reductions. Walgreens Boots Alliance had long been a member of the Dividend Aristocrats &mdash; companies that have increased their dividend for 25 consecutive years &mdash; <a href="https://www.nasdaq.com/articles/walgreens-stock-nasdaq:wba:-dividend-slashed-after-47-years.-blessing-in-disguise">but reduced its dividend in January</a>, shocking investors. Prior to that, the company last reduced its dividend in <a href="https://www.gurufocus.com/stock/WBA/dividend">1976</a>.



That is troublesome enough but the other problem with Walgreens Boots Alliance and the reason investors should avoid it entirely has to do with its lack of competitiveness. The company simply does not derive high margins from its sales. It isn&rsquo;t competitive relative to others within its industry.



Forbes recently compared Walgreens to CVS (NYSE:<a href="https://investorplace.com/stock-quotes/cvs-stock-quote/">CVS</a>) and found <a href="https://www.forbes.com/sites/greatspeculations/2024/06/05/after-a-40-fall-is-walgreens-stock-a-better-pick-over-cvs-health/">CVS outperforms it on a number of important metrics</a>. Surprisingly, Forbes also suggested it expects WBA to outperform CVS in the future solely because it is relatively underpriced compared to its rival. That logic is entirely backward. WBA shares are cheaper than those from CVS precisely because it underperforms, not because it&rsquo;s been unfairly maligned.&nbsp;



<h2>Service Properties Trust (SVC)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/reits1600c-300x169.jpg" alt="tiny house figures atop letter blocks spelling out REIT, representing reits to buy. stock predictions. best REITs"><div>Source: Shutterstock</div></div>Service Properties Trust (NASDAQ:<a href="https://investorplace.com/stock-quotes/svc-stock-quote/">SVC</a>) stock represents a real estate investment trust (REIT) focused on hotels and service-related properties. The company continues on a long-term decline, which will affect its dividend again at some point or another.



The most dramatic decline for the stock occurred in 2020 at the onset of the pandemic. Revenues declined by <a href="https://stockanalysis.com/stocks/svc/financials/">more than 45% that year</a> sending shares tumbling from $22 to $5. However, the stock had been trending downward for the previous five years as well. So, it&rsquo;s not as if Service Properties Trust simply was a victim of the pandemic.



The global health crisis prompted a <a href="https://www.gurufocus.com/stock/SVC/dividend">dividend reduction in 2021</a>. The company has not been able to regain net overall profitability since the pandemic. While the company continues to pay dividends, the funds from operations (FFO) from which dividends are paid, <a href="https://s2.q4cdn.com/208827006/files/doc_financials/2024/q1/a3ae6d5e-6999-4619-bb06-24216bd0b8e6.pdf">declined by 43%</a> in the most recent quarter. Normalized FFO was $0.13 per share in Q1 but distributions amounted to $0.20 per share. That is unsustainable.



<h2>AGNC Investment (AGNC)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/reits1600b-300x169.jpg" alt="Real estate investment trust (REIT) on a black notebook on an office desk."><div>Source: Shutterstock</div></div>AGNC Investment (NASDAQ:<a href="https://investorplace.com/stock-quotes/agnc-stock-quote/">AGNC</a>) is another REIT stock that investors should be wary of. The firm provides capital for mortgage-backed securities (MBS) guaranteed by the U.S. government. That&rsquo;s the same investment vehicle that proved so disastrous not so many years ago.



There are legitimate reasons to believe that AGNC stock will punish shareholders again. Previously I mentioned the payout ratio is an excellent predictor of the overall health of a given dividend. However, it isn&rsquo;t particularly applicable to REITs. So, AGNC Investment&rsquo;s <a href="https://www.gurufocus.com/stock/AGNC/dividend">payout ratio of 1.58</a> doesn&rsquo;t mean the company is necessarily unhealthy.&nbsp;



For REITs we must instead look at funds from operations (FFO) as a predictor of dividend stability. That&rsquo;s where the problem emerges. The company&rsquo;s <a href="https://www.gurufocus.com/term/ffo-per-share/AGNC">FFO is all over the place</a>. One quarter it&rsquo;s positive, the next it&rsquo;s negative.



It&rsquo;s fine to be wary of AGNC Investment because of the history of mortgage-backed securities. If that isn&rsquo;t enough to scare you away, simply look at the unpredictable FFO from the company.



<h2>Kohl&rsquo;s (KSS)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/08/kohls-stock-300x169.jpg" alt="Image of Kohl's logo on a Kohl's store"><div>Source: Sundry Photography/Shutterstock.com</div></div>Kohl&rsquo;s (NYSE:<a href="https://investorplace.com/stock-quotes/kss-stock-quote/">KSS</a>) stock is probably best avoided. The well-known department store retailer operates in a sensitive consumer discretionary sector and has not been doing well for several years.



A cursory view of Kohl&rsquo;s performance hisotry should give investors a few strong clues as to why it&rsquo;s to be avoided, especially for income investors. The stock&rsquo;s dividend yield is near 9% at the moment which is generally considered to be unhealthy. Its payout ratio is also above the healthy range, <a href="https://www.gurufocus.com/stock/KSS/dividend">at 0.81</a>.&nbsp;



That means 81% of earnings are directed toward paying dividends. That is simply too high and especially so given the poor operational performance of Kohl&rsquo;s overall. The company could certainly redirect those earnings toward improvements otherwise.&nbsp;



Here&rsquo;s what&rsquo;s really strange about Kohl&rsquo;s: The company&rsquo;s best year of late came in 2021 when revenues grew by more than 20%. That was the <a href="https://stockanalysis.com/stocks/kss/financials/">only year of the past five in which Kohl&rsquo;s showed overall revenue growth</a>. However, the company also reduced its dividend in 2021. There&rsquo;s simply too much variance in Kohl&rsquo;s operations.



<h2>Ardagh Metal Packaging (AMBP)&nbsp;</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/09/aluminum-stocks-cans-1600-300x169.jpg" alt="close-up of aluminum cans in assembly line"><div>Source: shutterstock.com/MOLPIX</div></div>Ardagh Metal Packaging (NYSE:<a href="https://investorplace.com/stock-quotes/ambp-stock-quote/">AMBP</a>) makes metal beverage cans used for beer, soft drinks, and all other beverages. The stock also provides a dividend yielding more than 10%, making it attractive to income investors.&nbsp;



The dividend has yielded more than 15% at times within the last few years. That level of yield will certainly entice some investors. However, Ardagh Metal Packaging also reduced its <a href="https://www.gurufocus.com/stock/AMBP/dividend">dividend</a> in 2022, suggesting it isn&rsquo;t dependable overall.



The primary reason is Ardagh&rsquo;s debt. The can maker&nbsp;doesn&rsquo;t have enough capital to cover its interest, which is highly concerning. That is leading the company into a <a href="https://www.gurufocus.com/stock/AMBP/analysis/warning-signs">vicious cycle by which it issues additional debt</a> in order to make up the difference.&nbsp;



High-risk-seeking investors might enjoy the roller coaster ride the stock will offer. Those who can sit back and collect a 10% return from dividends alone could certainly make out well. However, the company&rsquo;s poor operations mean it&rsquo;s likely to reduce that dividend again at some point. Once it does, there&rsquo;s no reason to be invested in Ardagh Metal Packaging.&nbsp;



<h2>Brandywine Realty Trust (BDN)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/04/office-1600-300x169.png" alt="Group of colleagues discuss something in an office conference room. commercial real estate"><div>Source: GaudiLab / Shutterstock</div></div>Brandywine Realty Trust (NYSE:<a href="https://investorplace.com/stock-quotes/bdn-stock-quote/">BDN</a>) is an office REIT stock, which will automatically raise warning alarms for many investors. Urbanization trends partially due to other trends such as remote work have introduced substantial risk to office REIT stocks.&nbsp;



Revenue growth was under 2% throughout 2023. Overall though, it was positive, marking the <a href="https://stockanalysis.com/stocks/bdn/financials/">second consecutive year of revenue growth</a> for the company. Prior to that, Brandywine Realty Trust had seen its revenues decline in each of the previous two years.



Despite modest revenue growth, the company reported a net loss in excess of $197 million in 2023. Net income is particularly concerning and is highly variable. To put a fine point on the stock, it&rsquo;s very difficult to find a rational business case for investing in Brandywine Realty Trust. Yes, the dividend currently offers a forward yield of 13.23% but it was reduced in <a href="https://www.gurufocus.com/stock/BDN/dividend">2023</a>. The payout&rsquo;s continued payment is hardly a foregone conclusion.&nbsp;



For now, Brandywine Realty Trust&rsquo;s FFO continues to cover its dividend payouts. However, the combination of <a href="https://investor.brandywinerealty.com/news-releases/news-release-details/brandywine-realty-trust-announces-first-quarter-2024-results-and">net losses that tripled in Q1, declining overall funds from operations</a> and overarching concerns related to office REITs makes BDN too risky. The 13.2% dividend looks like a siren song to me.



<h2>B&amp;G Foods (BGS)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/01/plant-based-food-1600-300x169.png" alt="On a white table sits bowls of nuts, fruit, and seeds, while vegetables like brocolli, carrots, and mushrooms sit on the table"><div>Source: Tatjana Baibakova / Shutterstock</div></div>B&amp;G Foods (NYSE:<a href="https://investorplace.com/stock-quotes/bgs-stock-quote/">BGS</a>) is a packaged food manufacturer with a stock offering a dividend yielding 8.1% at the moment.



There are several indications that the dividend is unsustainable. For one, it was recently reduced in 2023. It&rsquo;s also been shrinking over the past five years at an annual rate of more than 13%. If those two factors weren&rsquo;t enough to dissuade some investors, its <a href="https://www.gurufocus.com/stock/BGS/dividend">payout ratio should</a> be. That ratio sits at 0.84, meaning 84% of earnings are directed toward dividend payments.&nbsp;



If the company&rsquo;s overall business were improving then perhaps it would be logical to try to find a silver lining. However, B&amp;G Foods has real problems that show up on the income statement under other operating expenses. These costs have <a href="https://stockanalysis.com/stocks/bgs/financials/">ballooned over the past two fiscal years</a>. 



B&amp;G doesn&rsquo;t break them out in detail so it&rsquo;s difficult to know exactly what is going on. However, the net effect is the company has been losing money over the past two years, whereas it hadn&rsquo;t been prior.&nbsp;That puts the dividend at further risk in the future.&nbsp;



On the date of publication, Alex Sirois did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/"> Publishing Guidelines</a>.
<div>Alex Sirois is a freelance contributor to InvestorPlace whose personal stock investing style is focused on long-term, buy-and-hold, wealth-building stock picks. Having worked in several industries from e-commerce to translation to education and utilizing his MBA from George Washington University, he brings a diverse set of skills through which he filters his writing.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/06/7-at-risk-dividend-stocks-investors-should-sell-before-its-too-late/">7 At Risk Dividend Stocks Investors Should Sell Before It&#8217;s Too Late</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Government Trades

Ardagh Metal Packaging SA

top performing AMBP trades